A food supplement, with 100% natural ingredients, obtained from the plant species Vicia faba L. a natural source of L-Dopa.

Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients 2020, 12(3):747.

Cacabelos R, Carrera I, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Tellado I, Cacabelos N, Pego R, Carril JC. Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease. Planta Med. 2019, 85(17):1351-1362.

Teijido O.; Cacabelos R. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases. Int. J. Mol. Sci. 2018, 19, 3199.

Carrera I, Fernandez-Novoa L, Sampedro C, Tarasov VV, Aliev G, Cacabelos R. Dopaminergic Neuroprotection with AtreMorine in Parkinson's Disease.. Current Medicinal Chemistry 2018, 25: 5372.

Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. Chapter 6 - Basic and Clinical Studies With Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, 2018, Pages 195-225.

Cacabelos R, Carril JC, Cacabelos P, Fernández-Novoa L, Arun M. Pharmacogenetics of Neurodegenerative disorders. Internal Medicine Review 2017, 3. 10.18103/imr.v3i6.472.

Cacabelos R. Parkinson's Disease: From Pathogenesis to Pharmacogenomics. Int. J. Mol. Sci. 2017, 18(3), 551.

Cacabelos R, Carril JC, Teijido O. Chapter 5. Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Anti-aging Drugs: From Basic Research to Clinical Practice 2017, 75-141.

Romero A, Parada E, González-Lafuente L, Farré-Alins V, Ramos E, Cacabelos R, Egea J. Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®) . CNS Neurosci Ther 2017, 23:450-452.

Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R. Neuroprotective Effect of AtreMorine in an Experimental Model of Parkinson's disease. Current Pharmaceutical Design 2017, Vol 23 (18): 2673-2684(12).

Cacabelos R. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci 2016, 6:6.

Cacabelos R, Fernández-Novoa L, Alejo R, Corzo L, Alcaraz M, Nebril L, Cacabelos P, Fraile C, Carrera I and Carril JC. E-PodoFavalin-15999 (Atremorine®)-Induced Neurotransmitter and Hormonal Response in Parkinson's disease. J Exp Res Pharm 2016, 1(1):1-12.

Cacabelos R, Fernández-Novoa L, Alejo R, Corzo L, Alcaraz M, Nebril L, Cacabelos P, Fraile C, Carrera I and Carril JC. E-PodoFavalin-15999 (Atremorine®)-Induced Dopamine Response in Parkinson's disease: Pharmacogenetics-Related Effects. Gen Med Pharm 2016, 1(1):1-26.